ArticleResearch square2026
MEF2C controls lysosomal and lipid clearance programs linked to Alzheimer's disease risk in macrophages.
Anna Podlesny-Drabiniok et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it